Literature DB >> 13525578

Immunoreactions involving platelets. I. A steric and kinetic model for formation of a complex from a human antibody, quinidine as a haptene, and platelets; and for fixation of complement by the complex.

N R SHULMAN.   

Abstract

A steric and kinetic model for the sequence and mechanism of reactions leading to formation of a complex from an antibody, a haptene (quinidine), and a cell membrane (platelets), and to fixation of complement by the complex was deduced from the effects of varying the initial concentration of each component of the complex on the amount of complement fixed, from kinetic aspects of the sequential reactions, and from other chemical and physical properties of the various components involved. Theoretical results calculated using equations based on the model, which were derived by Dr. Terrell L. Hill, were similar in all respects to experimental results. Results of this study were consistent with the possibilities that the protein moiety of a haptenic antigen involved in development of an antibody which attaches to a cell is not necessarily a component of the cell, and that the cell reacts with the antibody by virtue of having a surface favorable for non-specific adsorption of certain haptene-antibody complexes.

Entities:  

Keywords:  PURPURA, THROMBOPENIC/immunology; QUINIDINE

Mesh:

Substances:

Year:  1958        PMID: 13525578      PMCID: PMC2136848          DOI: 10.1084/jem.107.5.665

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  8 in total

1.  Thrombocytopenic purpura due to quinidine. II. Serologic mechanisms.

Authors:  F G BOLTON
Journal:  Blood       Date:  1956-06       Impact factor: 22.113

2.  Platelet agglutinins and lysins in the pathogenesis of thrombocytopenic purpura, with a note on platelet groups.

Authors:  J F ACKROYD
Journal:  Br Med Bull       Date:  1955       Impact factor: 4.291

3.  The structure of antigen-antibody aggregates and complement fixation.

Authors:  J MARRACK
Journal:  Annu Rev Microbiol       Date:  1955       Impact factor: 15.500

4.  The role of sedormid in the immunological reaction that results in platelet lysis in sedormid purpura.

Authors:  J F ACKROYD
Journal:  Clin Sci       Date:  1954-08       Impact factor: 6.124

5.  An improved micro hematocrit method.

Authors:  M M STRUMIA; A B SAMPLE; E D HART
Journal:  Am J Clin Pathol       Date:  1954-09       Impact factor: 2.493

6.  The pathogenesis of thrombocytopenic purpura due to hypersensitivity to sedormid.

Authors:  J F ACKROYD
Journal:  Clin Sci       Date:  1949-04       Impact factor: 6.124

7.  Morphology and enumeration of human blood platelets.

Authors:  G BRECHER; E P CRONKITE
Journal:  J Appl Physiol       Date:  1950-12       Impact factor: 3.531

8.  Immunochemistry.

Authors:  M M MAYER
Journal:  Annu Rev Biochem       Date:  1951       Impact factor: 23.643

  8 in total
  25 in total

1.  QUINIDINE-INDUCED THROMBOCYTOPENIC PURPURA.

Authors:  E C STRATFORD; K R TANAKA
Journal:  Calif Med       Date:  1965-04

2.  Immunoreactions involving platelet. VI. Reactions of maternal isoantibodies responsible for neonatal purpura. Differentiation of a second platelet antigen system.

Authors:  N R SHULMAN; R H ASTER; H A PEARSON; M C HILLER
Journal:  J Clin Invest       Date:  1962-05       Impact factor: 14.808

3.  IMMUNOREACTIONS INVOLVING PLATELETS. V. POST-TRANSFUSION PURPURA DUE TO A COMPLEMENT-FIXING ANTIBODY AGAINST A GENETICALLY CONTROLLED PLATELET ANTIGEN. A PROPOSED MECHANISM FOR THROMBOCYTOPENIA AND ITS RELEVANCE IN "AUTOIMMUNITY".

Authors:  N R Shulman; R H Aster; A Leitner; M C Hiller
Journal:  J Clin Invest       Date:  1961-09       Impact factor: 14.808

4.  Binding of quinine- and quinidine-dependent drug antibodies to platelets is mediated by the Fab domain of the immunoglobulin G and is not Fc dependent.

Authors:  M E Smith; D M Reid; C E Jones; J V Jordan; C A Kautz; N R Shulman
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

Review 5.  [Pathophysiology and clinical data of complement].

Authors:  G Riethmüller
Journal:  Klin Wochenschr       Date:  1969-01-01

6.  A platelet and granulocyte membrane defect in paroxysmal nocturnal hemoglobinuria: usefulness for the detection of platelet antibodies.

Authors:  R H Aster; S E Enright
Journal:  J Clin Invest       Date:  1969-07       Impact factor: 14.808

7.  Drug-induced thrombocytopenia.

Authors:  P J Handagama; B F Feldman
Journal:  Vet Res Commun       Date:  1986-01       Impact factor: 2.459

8.  Fab-mediated binding of drug-dependent antibodies to platelets in quinidine- and quinine-induced thrombocytopenia.

Authors:  D J Christie; P C Mullen; R H Aster
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

9.  Heparin-induced thrombocytopenia, thrombosis, and hemorrhage.

Authors:  D Silver; D N Kapsch; E K Tsoi
Journal:  Ann Surg       Date:  1983-09       Impact factor: 12.969

10.  Antigenic differences between human platelets and megakaryocytes.

Authors:  P Hyde; D Zucker-Franklin
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.